EUVIMEDEUVIMED entdecken
Crossref

Postoperative Outcomes in Body Contouring Procedures Following Glucagon-Like Peptide-1 Receptor Agonist Use: A 10-Year Analysis

Joey Liang iD, Tara Pillai, Sakshi Chopra, Jackson M Cathey, Ash Patel

Aesthetic Surgery Journal · 16.04.2025 · 45 (5) · 501-507

DOI: 10.1093/asj/sjaf029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 17.02.2025. Verfasst von Joey Liang und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Body Contouring, Postoperative Complications. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Utilization of glucagon-like peptide-1 receptor agonists (GLP-1ras) has increased dramatically in recent years. Although GLP-1ras appear safe to use overall, it remains unclear whether preoperative GLP-1ra use impacts body contouring surgery outcomes.

Objectives

This study evaluates the postoperative course of patients receiving body contouring procedures by GLP-1ra use.

Methods

This retrospective cohort study examined patients who received panniculectomies, brachioplasties, thighplasties, and abdominoplasties at a large academic institution between November 2014 and November 2024. Propensity score–matched analysis paired cohorts by age, smoking status, and BMI and hemoglobin A1c at the time of surgery. Univariate analyses and multivariable logistic regression were performed.

Results

In total, 590 patients were included in this study. Of these, 100 patients utilized GLP-1ras before surgery. Propensity score–matched analysis paired 72 GLP-1ra and 143 non-GLP-1ra patients. Thirty day readmissions and emergency department visits in matched and unmatched cohorts were similar by GLP-1ra use (P > .05). Postoperative cellulitis occurred less frequently among GLP-1ra users in matched cohorts (P = .008); however, GLP-1ra use status did not predict cellulitis on multivariable logistic regression. Duration of GLP-1ra use and timing of discontinuation before surgery did not predict the incidence of wound dehiscence, seromas, or hematomas. Patients using GLP-1ras for obesity had lower rates of wound dehiscence than patients using GLP-1ras for diabetes (P = .028).

Conclusions

Compared with non-GLP-1ra controls, GLP-1ra users have similar postoperative outcomes following body contouring surgery. Wound dehiscence is more prevalent among patients taking GLP-1ras for diabetes compared with weight loss, potentially because of worse glycemic control or associated comorbidities. Level of Evidence: 3 (Therapeutic)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsBody ContouringPostoperative ComplicationsHumansFemaleMaleRetrospective StudiesMiddle AgedAdultTreatment OutcomePropensity ScoreAgedPatient Readmission

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

ORCID-Profile: Joey Liang

Zitieren

APA

Liang, J., Pillai, T., Chopra, S., Cathey, J. M., & Patel, A. (2025). Postoperative Outcomes in Body Contouring Procedures Following Glucagon-Like Peptide-1 Receptor Agonist Use: A 10-Year Analysis. Aesthetic Surgery Journal, 45(5), 501-507. https://doi.org/10.1093/asj/sjaf029

Vancouver

Liang J, Pillai T, Chopra S, Cathey JM, Patel A. Postoperative Outcomes in Body Contouring Procedures Following Glucagon-Like Peptide-1 Receptor Agonist Use: A 10-Year Analysis. Aesthetic Surgery Journal. 2025;45(5):501-507. doi:10.1093/asj/sjaf029

BibTeX
@article{Liang2025,
  author = {Liang, Joey and Pillai, Tara and Chopra, Sakshi and Cathey, Jackson M and Patel, Ash},
  title = {Postoperative Outcomes in Body Contouring Procedures Following Glucagon-Like Peptide-1 Receptor Agonist Use: A 10-Year Analysis},
  journal = {Aesthetic Surgery Journal},
  year = {2025},
  volume = {45},
  number = {5},
  pages = {501--507},
  doi = {10.1093/asj/sjaf029}
}
Kostenlos starten →